Related references
Note: Only part of the references are listed.Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion
Volker Rudolph et al.
CARDIOVASCULAR RESEARCH (2010)
Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition
Benjamin Keserue et al.
CARDIOVASCULAR RESEARCH (2010)
Hydrogen peroxide is the major oxidant product of xanthine oxidase
Eric E. Kelley et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Peroxisome proliferator-activated receptor γ in bladder cancer A promising therapeutic target
Jose J. Mansure et al.
CANCER BIOLOGY & THERAPY (2009)
Atomic structure of mutant PPARγ LBD complexed with 15d-PGJ2: Novel modulation mechanism of PPARγ/RXRα function by covalently bound ligands
Tsuyoshi Waku et al.
FEBS LETTERS (2009)
Inhibition of the Soluble Epoxide Hydrolase by Tyrosine Nitration
Eduardo Barbosa-Sicard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Transnitrosylating Nitric Oxide Species Directly Activate Type I Protein Kinase A, Providing a Novel Adenylate Cyclase-independent Cross-talk to β-Adrenergic-like Signaling
Joseph R. Burgoyne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
John D. Imig et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Nitro-oleic Acid, a Novel and Irreversible Inhibitor of Xanthine Oxidoreductase
Eric E. Kelley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease
Jan Monti et al.
NATURE GENETICS (2008)
Protein sulfenation as a redox sensor -: Proteomics studies using a novel biotinylated dimedone analogue
Rebecca L. Charles et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Modification and activation of ras proteins by electrophilic prostanoids with different structure are site-selective
Marta Renedo et al.
BIOCHEMISTRY (2007)
Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice
Ayala Luria et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The soluble epoxide hydrolase as a pharmaceutical target for hypertension
Nipavan Chiamvimonvat et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function
John M. Seubert et al.
CIRCULATION RESEARCH (2006)
Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells
EE Kelley et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Protein thiol oxidation in health and disease: Techniques for measuring disulfides and related modifications in complex protein mixtures
Philip Eaton
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Peroxisome proliferator-activated receptors and acute lung injury
Salvatore Cuzzocrea
CURRENT OPINION IN PHARMACOLOGY (2006)
15-Deoxy-delta12,14-prostaglandin J2, a neuroprotectant or a neurotoxicant?
SH Koh et al.
TOXICOLOGY (2005)
15d-PGJ2:: The anti-inflammatory prostaglandin?
JU Scher et al.
CLINICAL IMMUNOLOGY (2005)
A potential role of 15-deoxy-Δ12,14-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis
ZZ Shan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-γ (PPAR-γ), reduce ischaemia/reperfusion injury of the gut
S Cuzzocrea et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Thioredoxin as a molecular target of cyclopentenone prostaglandins
T Shibata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Ligands of the peroxisome proliferator-activated receptors (PPAR-γ and PPAR-α) reduce myocardial infarct size
NS Wayman et al.
FASEB JOURNAL (2002)
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation
CJ Sinal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Cellular response to bioactive lipid peroxidation products
K Uchida
FREE RADICAL RESEARCH (2000)
Share Paper
